These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 9144902)

  • 1. Applications of telomerase in urologic oncology.
    Landman J; Kavaler E; Droller MJ; Liu BC
    World J Urol; 1997; 15(2):120-4. PubMed ID: 9144902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Telomeres, telomerase and cancer: is the magic bullet real?
    Sharma HW; Maltese JY; Zhu X; Kaiser HE; Narayanan R
    Anticancer Res; 1996; 16(1):511-5. PubMed ID: 8615664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Telomeres, telomerase and cancer].
    Soria JC; Rixe O
    Bull Cancer; 1997 Oct; 84(10):963-70. PubMed ID: 9435798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Telomere length maintenance in aging and carcinogenesis.
    Aragona M; Maisano R; Panetta S; Giudice A; Morelli M; La Torre I; La Torre F
    Int J Oncol; 2000 Nov; 17(5):981-9. PubMed ID: 11029502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of telomerase in cell senescence and oncogenesis.
    Urquidi V; Tarin D; Goodison S
    Annu Rev Med; 2000; 51():65-79. PubMed ID: 10774453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A combination of semiquantitative telomerase assay and in-cell telomerase activity measurement using exfoliated urothelial cells for the detection of urothelial neoplasia.
    Ohyashiki K; Yahata N; Ohyashiki JH; Iwama H; Hayashi S; Ando K; Aizawa T; Ito T; Miki M; Ebihara Y
    Cancer; 1998 Dec; 83(12):2554-60. PubMed ID: 9874463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Telomere Dysfunction, Chromosomal Instability and Cancer.
    Meena J; Rudolph KL; Günes C
    Recent Results Cancer Res; 2015; 200():61-79. PubMed ID: 26376872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Telomerase as a diagnostic and therapeutic target for cancer.
    Doyle LA; Highsmith WE
    Expert Rev Anticancer Ther; 2002 Apr; 2(2):217-25. PubMed ID: 12113243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Telomerase inhibition and cancer: might platinum based drugs have a future as anti-telomerase pharmacological approach?
    Colangelo D; Osella D
    Curr Med Chem; 2005; 12(26):3091-102. PubMed ID: 16375703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Inhibition of telomeres and telomerase. Seeking for new anticancer drugs].
    Raymond E; Faivre S; Dieras V; Von Hoff D
    Bull Cancer; 1997 Dec; 84(12):1123-33. PubMed ID: 9587365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Telomeres, telomerase, and tumorigenesis--a review.
    Wai LK
    MedGenMed; 2004 Jul; 6(3):19. PubMed ID: 15520642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological intervention strategies for affecting telomerase activity: future prospects to treat cancer and degenerative disease.
    Tárkányi I; Aradi J
    Biochimie; 2008 Jan; 90(1):156-72. PubMed ID: 17945408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The implication of telomerase activity and telomere stability for replicative aging and cellular immortality (Review).
    Engelhardt M; Martens UM
    Oncol Rep; 1998; 5(5):1043-52. PubMed ID: 9683806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Agents that target telomerase and telomeres.
    Raymond E; Sun D; Chen SF; Windle B; Von Hoff DD
    Curr Opin Biotechnol; 1996 Dec; 7(6):583-91. PubMed ID: 8939642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of telomerase activity and telomere length.
    Wu KD; Moore MA
    Methods Mol Med; 2005; 113():207-23. PubMed ID: 15968105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Telomerase inhibition and the future management of head-and-neck cancer.
    McCaul JA; Gordon KE; Clark LJ; Parkinson EK
    Lancet Oncol; 2002 May; 3(5):280-8. PubMed ID: 12067805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Telomeres and telomerase: implications for cancer and aging.
    Shay JW; Wright WE
    Radiat Res; 2001 Jan; 155(1 Pt 2):188-193. PubMed ID: 11121233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative analysis of telomerase activity and telomere length in domestic animal clones.
    Betts DH; Perrault S; Harrington L; King WA
    Methods Mol Biol; 2006; 325():149-80. PubMed ID: 16761726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The design of G-quadruplex ligands as telomerase inhibitors.
    Cuesta J; Read MA; Neidle S
    Mini Rev Med Chem; 2003 Feb; 3(1):11-21. PubMed ID: 12570851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Telomerase inhibitors and 'T-oligo' as cancer therapeutics: contrasting molecular mechanisms of cytotoxicity.
    Rankin AM; Faller DV; Spanjaard RA
    Anticancer Drugs; 2008 Apr; 19(4):329-38. PubMed ID: 18454043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.